文献速递心外重症与机械循环支持

使用可解释机器学习算法识别晚期心力衰竭治疗的潜在候选者

Identifying potential candidates for advanced heart failure therapies using an interpretable machine learning algorithm.
PubMed 文献 · J Heart Lung Transplant · 2022-09-08

本研究基于REVIVAL和INTERMACS注册数据,开发了一种基于热带几何与模糊逻辑原理的机器学习模型,用于识别需评估晚期心衰治疗的患者。模型在4,694例心衰患者中训练和验证,F1分数43.8%、召回率51.1%、精确率46.9%,性能与常用模型相当,且能提供透明简明的临床规则。

要点

  • 模型在4,694例心衰患者中训练验证,F1分数43.8%、召回率51.1%、精确率46.9%。
  • 模型性能与常用机器学习模型相当,且为仅有的3个提供透明简明临床规则的模型之一,显著优于其他2个模型。
  • 从模型中提取了11条可用于临床实践的临床规则。

核心结论

  • 该机器学习模型能够接受临床知识并给出可及的建议,用于识别晚期心衰患者;该方法在其他重要临床应用中具有多种潜在用途。

研究设计与样本

  • 回顾性研究,使用REVIVAL注册和INTERMACS注册数据,开发基于热带几何与模糊逻辑原理的新型机器学习模型,在4,694例心衰患者中训练和验证。

主要发现

  • 模型以心衰和移植心脏科医生的临床知识启动时,F1分数为43.8%,召回率为51.1%,精确率为46.9%。
  • 模型性能与其他常用机器学习模型相当。
  • 模型是仅有的3个提供透明简明临床规则的模型之一,显著优于其他2个模型。
  • 从模型中提取了11条临床规则,可用于临床实践。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systems level barriers to heart failure (HF) care limit access to HF advanced therapies (heart transplantation, left ventricular assist devices). There is a need for automated systems that can help clinicians ensure patients with HF are evaluated for HF advanced therapies at the appropriate time to optimize outcomes. METHODS: We performed a retrospective study using the REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life) and INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) registries. We developed a novel machine learning model based on principles of tropical geometry and fuzzy logic that can accommodate clinician knowledge and provide recommendations regarding need for advanced therapies evaluations that are accessible to end-users. RESULTS: The model was trained and validated using data from 4,694 HF patients. When initiated with clinical knowledge from HF and transplant cardiologists, the model achieved an F1 score of 43.8%, recall of 51.1%, and precision of 46.9%. The model achieved comparable performance compared with other commonly used machine learning models. Importantly, our model was 1 of only 3 models providing transparent and parsimonious clinical rules, significantly outperforming the other 2 models. Eleven clinical rules were extracted from the model which can be leveraged in clinical practice. CONCLUSIONS: A machine learning model capable of accepting clinical knowledge and making accessible recommendations was trained to identify patients with advanced HF. While this model was developed for HF care, the methodology has multiple potential uses in other important clinical applications.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Yao H, Golbus JR, Gryak J, et al. Identifying potential candidates for advanced heart failure therapies using an interpretable machine learning algorithm. J Heart Lung Transplant. 2022. PMID: 36192320. doi:10.1016/j.healun.2022.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。